Cargando…

Raised liver enzymes in newly diagnosed Type 2 diabetes are associated with weight and lipids, but not glycaemic control

INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is associated with Type 2 diabetes (T2DM) and the metabolic syndrome, and can progress to chronic liver disease. We examined the incidence of elevated (>35 iu/l) alanine transaminase (ALT), as a surrogate marker for NAFLD, in patients with n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saligram, Shreyas, Williams, Elizabeth J., Masding, Michael G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510928/ https://www.ncbi.nlm.nih.gov/pubmed/23226654 http://dx.doi.org/10.4103/2230-8210.103027

Ejemplares similares

Raised liver enzymes in newly diagnosed type 2 diabetes
por: Joob, Beuy, et al.
Publicado: (2013)

Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Yoo, Soon-Jib, et al.
Publicado: (2021)

Dietary glycaemic index, glycaemic load and head and neck cancer risk: a pooled analysis in an international consortium
por: Chang, Chun-Pin, et al.
Publicado: (2020)

Ipsilateral Lymphadenopathy After COVID-19 Vaccination in Patients With Newly Diagnosed Breast Cancer
por: Ha, Su Min, et al.
Publicado: (2022)

Newly Diagnosed Infection After Admission for Acute Heart Failure: From the KCHF Registry
por: Seko, Yuta, et al.
Publicado: (2021)

A nurse‐led intervention in patients with newly diagnosed cancer and Type 2 diabetes: A pilot randomized controlled trial feasibility study
por: Scarton, Lisa, et al.
Publicado: (2023)

Determinants of Newly-Diagnosed Raised Blood Pressure: The Malaysian Context
por: LIM, Ooi Wei, et al.
Publicado: (2021)

Is glycaemic control associated with dietary patterns independent of weight change in people newly diagnosed with type 2 diabetes? Prospective analysis of the Early-ACTivity-In-Diabetes trial
por: Garbutt, James, et al.
Publicado: (2022)

Prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh, India
por: Thakur, Surender, et al.
Publicado: (2013)

Reduced Weekly Subcutaneous Doses of Bortezomib in Combination with Cyclophosphamide and Dexamethasone for Newly Diagnosed Multiple Myeloma
por: Ashrafi, Farzaneh, et al.
Publicado: (2020)

Donor Graft MicroRNAs: A Newly Identified Player in the Development of New‐onset Diabetes After Liver Transplantation
por: Ling, Q., et al.
Publicado: (2016)

Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7)
por: Colomban, Olivier, et al.
Publicado: (2020)

Incidence of newly diagnosed diabetes after Covid-19
por: Rathmann, Wolfgang, et al.
Publicado: (2022)

Dyslipidemia, metabolic syndrome, and liver enzymes in impaired glucose tolerance and new onset untreated, type 2 diabetes Indian subjects
por: Sanyal, Debmalaya, et al.
Publicado: (2012)

Accuracy of Endoscopic Ultrasound-guided Fine Needle Aspiration in Diagnosing Solid Pseudopapillary Tumor
por: Saligram, Shreyas, et al.
Publicado: (2013)

Real‐world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database
por: Mian, Hira, et al.
Publicado: (2022)

Association of serum lipids with diabetic retinopathy in type 2 diabetes
por: Agroiya, Puspalata, et al.
Publicado: (2013)

Prevalence of lean type 2 diabetes mellitus in recently diagnosed type 2 diabetes mellitus patients
por: Chaudhary, Prateek, et al.
Publicado: (2013)

Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3
por: Viljoen, Adie, et al.
Publicado: (2023)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
por: Liu, Chang-Yuan, et al.
Publicado: (2019)

Serum lipids and diabetic retinopathy: A cross-sectional study
por: Idiculla, Jyothi, et al.
Publicado: (2012)

Correlations between anthropometry and lipid profile in type 2 diabetics
por: Himabindu, Yalamanchali, et al.
Publicado: (2013)

Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study
por: Cariou, Bertrand, et al.
Publicado: (2021)

The association of depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years in newly diagnosed type 2 diabetes: a prospective cohort study
por: Ismail, Khalida, et al.
Publicado: (2017)

The Two Sides of Opioids in Cyclical Vomiting Syndrome
por: Saligram, Shreyas, et al.
Publicado: (2014)

The impact of individual cytochrome P450 enzymes on oxidative metabolism of benzo[a]pyrene in human livers
por: Šulc, Miroslav, et al.
Publicado: (2016)

Acute oral sodium propionate supplementation raises resting energy expenditure and lipid oxidation in fasted humans
por: Chambers, Edward S., et al.
Publicado: (2017)

Serum Soluble Epidermal Growth Factor Receptor Level Increase in Patients Newly Diagnosed with Type 2 Diabetes Mellitus
por: Kim, Ji Min, et al.
Publicado: (2018)

A case of severe increase of liver enzymes in a ATTRv patient after one year of inotersen treatment
por: Severi, Daniele, et al.
Publicado: (2022)

Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes
por: Matthews, David, et al.
Publicado: (2020)

The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in Sweden: A health economic modelling analysis based on nationwide data
por: Hellgren, Margareta, et al.
Publicado: (2021)

Controlling Lipids AIDS in the Prevention of Type 2 Diabetes, Hypertension, and Cardiovascular Diseases
por: Nayak, Shivananda B., et al.
Publicado: (2017)

Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice
por: Nakamura, Takashi, et al.
Publicado: (2021)

Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data
por: Peters, Anne, et al.
Publicado: (2020)

Predictors of dementia amongst newly diagnosed non-valvular atrial fibrillation patients
por: Batta, Akash, et al.
Publicado: (2022)

Exploring the competitive dynamic enzyme allocation scheme through enzyme cost minimization
por: Qi, Shanshan, et al.
Publicado: (2023)

Glycaemic benefit of iGlarLixi in insulin‐naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan‐O randomized trial
por: Davies, Melanie J., et al.
Publicado: (2019)

Impact of ethnicity on progress of glycaemic control in 131 935 newly diagnosed patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register
por: Rawshani, Araz, et al.
Publicado: (2015)

Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin‐metformin combination in newly diagnosed Type 2 diabetes
por: Matthews, D. R., et al.
Publicado: (2019)

Clinical Inertia and 2-Year Glycaemic Trajectories in Patients with Non-Newly Diagnosed Type 2 Diabetes Mellitus in Primary Care: A Retrospective Cohort Study
por: An, Ling-Wang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2528plo865gkthcls619df12q1